leisure time -WSS

leisure time

author：entertainment 2025-09-03 05:40:12 - browse：687

How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： UnitedHealth’s board chair also owns a personal investment firm

WSS

Juul spent big to court Black leaders to promote its e

STAT Summit: Michael J. Fox on progress in Parkinson's research

Commercial surrogacy can be ethical, despite pope’s claims

Medicare reduced heart disease by changing how it pays doctors

Juul spent big to court Black leaders to promote its e

Eli Lilly expects to double planned employment in Boston center

entertainment

leisure time

focus

Anesthesiologist group: stop taking Ozempic before surgery

STAT Readout Newsletter: Today's biggest biotech updates

Supreme Court strikes down use of affirmative action

Cognito secures funding to test medical device for Alzheimer's

Medical records are filled with copy

Studies point to risks of excluding people with obesity from drug trials

Medicare details structure of new drug price negotiation program

Medicare drug price negotiation’s day in court

At least 13 dead in Texas as scorching temps continue

STAT Summit: GSK CEO on pharma giant's new direction

knowledge

Woodcock on FDA’s accelerated approval and her next chapter

A $475,000 price tag for a new cancer drug: crazy or meh?

The real point of Kenneth Smith’s execution by nitrogen gas

Vertex non

STAT Summit: GSK CEO on pharma giant's new direction

Cognito secures funding to test medical device for Alzheimer's

focus

leisure time

hotspot

entertainment